GB:0IHV's free cash flow for Q4 2023 was $-13.63M. For the 2023 fiscal year, GB:0IHV's free cash flow was decreased by $61.25M and operating cash flow was $-13.37M. See a summary of the company’s cash flow.

Cash Flow	TTM	Jul 23	Jul 22	Jul 21	Jul 20	Jul 19
Operating Cash Flow	$ -41.66M	$ -36.98M	$ 750.00K	$ 7.39M	$ -17.18M	$ 4.81M
Investing Cash Flow	$ 99.38M	$ 98.98M	$ 25.22M	$ -34.50M	$ -2.17M	$ -8.13M
Financing Cash Flow	$ -1.55M	$ -1.13M	$ -241.00K	$ -7.24M	$ 7.00M	$ 4.19M
Cash Flow From Discontinued Operation	-	-	-	-	-	-
Other Cash Adjustment Inside Changein Cash	-	-	-	-	-	-
End Cash Position	$ 157.07M	$ 83.37M	$ 750.00K	$ 14.27M	$ 48.62M	$ 60.90M
Income Tax Paid Supplemental Data	-	-	-	-	-	-
Interest Paid Supplemental Data	-	-	-	-	-	-
Issuance Of Capital Stock	$ 386.00K	$ 386.00K	-	-	-	-
Issuance Of Debt	$ -8.09M	$ -8.14M	$ -269.00K	$ -339.00K	$ 7.41M	$ 4.50M
Repayment Of Debt	$ -24.94M	$ -24.98M	$ -269.00K	$ -339.00K	$ -411.00K	$ -404.00K
Free Cash Flow	$ 57.07M	$ 62.00M	$ 750.00K	$ 7.39M	$ -19.35M	$ -3.32M
Domestic Sales	-	-	-	-	-	-
Foreign Sales	-	-	-	-	-	-

Currency in USD

Enzo Biochem Cash Flow

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing